{"transactions":[{"id":4633153,"issuer":{"id":7681,"kind":"organization","name":"SPAR Group, Inc.","symbol":"SGRP"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-10-02T04:57:56.000Z","date":"2026-09-29","kind":"grant","planned":false,"acquired":true,"shares":110000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the company's common stock upon vesting. The RSUs will vest on September 29, 2027, subject to continued service."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001437749-26-031787","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1004989/000143774926031787/rdgdoc.xml","form_type":"4"}},{"id":827319,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option, which was granted on May 13, 2024, were fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827318,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":false,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The remaining shares underlying this option, which was granted on May 3, 2023, will vest one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, subject to the Reporting Person's continued service as a director."}],"balance_after":19600,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827317,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":39200,"price":4.89,"value":191688.0,"ownership":{"direct":true},"balance_after":123400,"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":827316,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T12:27:07.000Z","date":"2026-03-24","kind":"exercise","planned":false,"acquired":true,"shares":39200,"price":4.97,"value":194824.0,"ownership":{"direct":true},"balance_after":84200,"source":{"system":"sec-edgar","filing":"0001612084-26-000002","document":"wk-form4_1774528025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208426000002/wk-form4_1774528025.xml","form_type":"4"}},{"id":921806,"issuer":{"id":8169,"kind":"organization","name":"Newton Golf Company, Inc."},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T01:58:32.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":18549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units will vest in full on the one year anniversary of the grant date."}],"balance_after":18549,"source":{"system":"sec-edgar","filing":"0001493152-26-004958","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000149315226004958/ownership.xml","form_type":"4"}},{"id":1060212,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-20T20:38:00.000Z","date":"2025-08-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":9.165,"value":45825.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001437749-25-027456","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925027456/rdgdoc.xml","form_type":"4"}},{"id":1129208,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-31T01:38:03.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 29, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's tenth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) the date that is one day prior to the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":8.62,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-25-019045","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925019045/rdgdoc.xml","form_type":"4"}},{"id":1194603,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-21T20:06:49.000Z","date":"2025-03-19","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":7.9624,"value":79624.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001437749-25-008738","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774925008738/rdgdoc.xml","form_type":"4"}},{"id":1454564,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-15T20:10:52.000Z","date":"2024-07-12","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":5.8661,"value":58661.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.81 to $5.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001437749-24-022734","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774924022734/rdgdoc.xml","form_type":"4"}},{"id":1515921,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-16T01:31:46.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":39200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 13, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant, (ii) one day prior to the date of the first annual meeting of the Issuer's stockholders following the date of grant or (iii) immediately prior to a change in control of the Issuer, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":39200,"derivative":{"exercise_price":4.89,"expiration_date":"2034-05-12","underlying":"Common Stock","underlying_shares":39200},"source":{"system":"sec-edgar","filing":"0001437749-24-017190","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774924017190/rdgdoc.xml","form_type":"4"}},{"id":1787130,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-06T20:40:44.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":5.1333,"value":51333.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001437749-23-025313","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923025313/rdgdoc.xml","form_type":"4"}},{"id":1884578,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":2451,"price":5.05,"value":12377.55,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1884577,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":5.045,"value":504.5,"ownership":{"direct":true},"balance_after":7549,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1884576,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":4759,"price":5.04,"value":23985.36,"ownership":{"direct":true},"balance_after":7449,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1884575,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.0399,"value":5039.9,"ownership":{"direct":true},"balance_after":2690,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1884574,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":5.0391,"value":1511.73,"ownership":{"direct":true},"balance_after":1690,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1884573,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T21:53:37.000Z","date":"2023-05-18","kind":"purchase","planned":false,"acquired":true,"shares":1390,"price":5.035,"value":6998.65,"ownership":{"direct":true},"balance_after":1390,"source":{"system":"sec-edgar","filing":"0001437749-23-015335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923015335/rdgdoc.xml","form_type":"4"}},{"id":1900929,"issuer":{"id":5212,"kind":"organization","name":"ZEVRA THERAPEUTICS, INC.","symbol":"ZVRA"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-05-09T01:44:43.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, May 3, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"33.33% of the total shares subject to the option vest in equal annual installments beginning one day prior to the date of the first annual meeting of the Issuer's stockholders following the day of grant and continuing for the next two annual meeting of the Issuer's stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the Issuer's stockholders following the day of the grant, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer."}],"balance_after":58800,"derivative":{"exercise_price":4.97,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001437749-23-013121","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000143774923013121/rdgdoc.xml","form_type":"4"}},{"id":2457875,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:25:33.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":502008,"price":0.0249,"value":12499.9992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":10500984,"source":{"system":"sec-edgar","filing":"0001612084-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208421000003/primary_doc.xml","form_type":"4"}},{"id":2457874,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:25:33.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":592417,"price":0.0211,"value":12499.9987,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":9998976,"source":{"system":"sec-edgar","filing":"0001612084-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208421000003/primary_doc.xml","form_type":"4"}},{"id":2457873,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T21:25:33.000Z","date":"2021-05-31","kind":"grant","acquired":true,"shares":396825,"price":0.0315,"value":12499.9875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":9406559,"source":{"system":"sec-edgar","filing":"0001612084-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208421000003/primary_doc.xml","form_type":"4"}},{"id":2745102,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T20:49:13.000Z","date":"2021-02-28","kind":"grant","acquired":true,"shares":459559,"price":0.0272,"value":12500.0048,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":9009734,"source":{"system":"sec-edgar","filing":"0001612084-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208421000001/primary_doc.xml","form_type":"4"}},{"id":2745101,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-19T20:49:13.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":1420455,"price":0.0088,"value":12500.004,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":8550175,"source":{"system":"sec-edgar","filing":"0001612084-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208421000001/primary_doc.xml","form_type":"4"}},{"id":3007190,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T22:10:05.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":675676,"price":0.0185,"value":12500.006,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":7129720,"source":{"system":"sec-edgar","filing":"0001612084-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208420000001/primary_doc.xml","form_type":"4"}},{"id":3007189,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T22:10:05.000Z","date":"2020-05-31","kind":"grant","acquired":true,"shares":2604167,"price":0.0048,"value":12500.0016,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":6454044,"source":{"system":"sec-edgar","filing":"0001612084-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208420000001/primary_doc.xml","form_type":"4"}},{"id":3007188,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T22:10:05.000Z","date":"2020-02-29","kind":"grant","acquired":true,"shares":2083333,"price":0.006,"value":12499.998,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":3849877,"source":{"system":"sec-edgar","filing":"0001612084-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208420000001/primary_doc.xml","form_type":"4"}},{"id":3007187,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T22:10:05.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":781250,"price":0.016,"value":12500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":1766544,"source":{"system":"sec-edgar","filing":"0001612084-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208420000001/primary_doc.xml","form_type":"4"}},{"id":3007186,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-14T22:10:05.000Z","date":"2018-08-31","kind":"grant","acquired":true,"shares":490196,"price":0.0255,"value":12499.998,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Independent Director Compensation"}],"balance_after":985294,"source":{"system":"sec-edgar","filing":"0001612084-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208420000001/primary_doc.xml","form_type":"4"}},{"id":3465230,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-09T16:46:25.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":245098,"price":0.051,"value":12499.998,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. Restricted stock, to be vested, common shares with a value of $12,500 on each of May 31, 2019; August 31, 2019; November 30, 2019; and February 29, 2020, pursuant to an Independent Director Agreement dated March 1, 2019."}],"balance_after":495098,"source":{"system":"sec-edgar","filing":"0001612084-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208419000001/primary_doc.xml","form_type":"4"}},{"id":3987637,"issuer":{"id":131111,"kind":"organization","name":"FISION Corp","symbol":"FSSN"},"owners":[{"id":55828,"kind":"person","name":"Bode John B","position":1,"cik":"0001612084","reported_name":"Bode John B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-20T21:01:32.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":250000,"price":0.2,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock, to be vested quarterly as follows: 62,500 shares on May 31, 2018; 62,500 shares on August 31, 2018; 62,500 shares on November 30, 2018; and 62,500 shares on February 28, 2019, pursuant to an Independent Director Agreement."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001612084-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1612084/000161208418000002/primary_doc.xml","form_type":"4"}}]}